Market Exclusive

Analyst Activity – Barclays Lowers Its Price Target On NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) to $55.00

Analyst Ratings For NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)

Today, Barclays lowered its price target on NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) to $55.00 per share.

Some recent analyst ratings include

Dividend information for NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)

NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) pays an annual dividend of $1.60 with a yield of 3.07% and an average dividend growth of 2.70% based on a 3 Year Average..

Dividend History for NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)

Recent Insider Trading Activity For NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)
NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) has insider ownership of 0.23% and institutional ownership of 71.58%.

Recent Trading Activity for NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)
Shares of NYSE:BMY – Bristol-Myers Squibb closed the previous trading session at 52.16 up +0.12 0.23% with 3700569 shares trading hands.

Exit mobile version